Bayer AG BAYRY OTC

Bayer AG (BAYRY) has shown declining revenue growth over the past 3 years, expanding from $50.7B to $43.8B (average -4.8%/yr). The company reported a net loss of $3.5B in its most recent fiscal year, with earnings trending at -64.6%/yr. The net profit margin is -7.9%, which is negative. the company was profitable in 1 out of the last 4 years tracked. The gross margin is 59.2% (high), with a -1.6pp trend over the period. With a $47B market cap and MOAT composite score of 80/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (15/100, Fail) — revenue or earnings are not growing
• PAST (25/100, Fail) — the company has frequently reported losses. Looking at the full 28-year history, the company was profitable in 23 of 28 years — a solid long-term record with occasional losses
• INCOME (10/100, Fail) — the company is currently operating at a loss
• MOAT (80/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 33/100 with 1/6 criteria passed.